Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-205] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal SPIKE antibody. Carrier free. Suitable for I-ELISA and reacts with Recombinant full length protein - SARS-CoV-2 samples.
View Alternative Names
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- I-ELISA
Supplier Data
Indirect ELISA - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-205] - BSA and Azide free (AB283951)
Indirect ELISA showing primary antibody ab283950 binding to recombinant human coronavirus SARS-CoV-2 spike glycoprotein S1 (Fc Chimera, ab272105), SARS-CoV-2 spike S1+S2 ECD-His recombinant protein, SARS-CoV spike S1+S2 ECD-His recombinant protein and recombinant human coronavirus SARS-CoV-2 spike glycoprotein RBD (His tagged, ab275986) .
Plates were coated with recombinant human coronavirus SARS-CoV-2 spike glycoprotein S1 (Fc Chimera, ab272105), SARS-CoV-2 spike S1+S2 ECD-His recombinant protein, SARS-CoV spike S1+S2 ECD-His recombinant protein and recombinant human coronavirus SARS-CoV-2 spike glycoprotein RBD (His tagged, ab275986) at 1000 ng/ml. Binding of ab283950 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).
Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.
This data was developed using the same antibody clone in a different buffer formulation ab283950.
This data was developed using ab283950, the same antibody clone in a different buffer formulation.
- I-ELISA
Lab
Indirect ELISA - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-205] - BSA and Azide free (AB283951)
Indirect ELISA showing primary antibody ab283950 binding to SARS-CoV-2 (Omicron variant) Spike Glycoprotein S1; SARS-CoV-2 (Omicron variant) Spike Glycoprotein RBD; SARS-CoV-2 Omicron variant Spike protein (GCN4-IZ) His tag; Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera). Antigen concentration is 1000 ng/ml. Substrate solution is p-nitrophenyl phosphate(PNPP). Binding of ab283950 was assessed in a serial dilution range 1000-0 ng/ml. Binding was detected using the secondary antibody, Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at 1/2500 dilution. This data was developed using ab283950, the same antibody clone in a different buffer formulation.
Related conjugates and formulations (1)
-
Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-205]
Reactivity data
Product details
ab283951 is the carrier-free version of ab283950.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The spike glycoprotein S1 mediates the fusion of the viral and cellular membranes which is necessary for viral entry. It forms part of a larger trimeric complex comprising S1 and S2 subunits. This complex undergoes conformational changes that drive the membrane fusion process. The glycoprotein contains multiple glycosylation sites which help shield the virus from the host immune response. The proper function and presentation of this glycoprotein are critical for efficient viral spread and infection establishment.
Pathways
The spike glycoprotein S1 is integral to the viral infection pathway and host immune evasion. It interacts with the renin-angiotensin system by binding to the ACE2 receptor disrupting normal receptor activity. This interaction not only facilitates viral entry but also impacts the homeostatic functions typically mediated by ACE2 which include blood pressure regulation. Additionally the spike protein is involved in downstream activation of immune signaling pathways including those related to inflammation and cytokine production which may involve proteins such as IL-6.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com